Clinical trial NCT06630026: Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients with Parkinson's Diagnosis Living in Turkey
Official title: Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients with Parkinson's Diagnosis Living in Turkey
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Parkinson Disease
Falls
Scale Reliability Validity
Keywords: Parkinson disease
Falls
Scale reliability validity
Lead sponsor: Istanbul Medeniyet University
Sponsor class: OTHER
First posted: 2024-10-08
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Parkinson patients who are aged 18-80 years with Hoehn \& Yahr score between 1-4 and able to speak and read Turkish.

Brief summary: The aim of this study is to adapt the Dresden Falls Questionnaire scale (DREFAQ) to Turkish society and to make its validity and reliability in Turkish. The DREFAQ) scale developed by Frank, Anika, et al assesses falls in patients with Parkinson. It has 5 questions. This study will be conducted with Parkinson patients. The patients will be sought to answer questionnaires during regular rehabilitation sessions. 50 participants will be included in the study. In order to evaluate the validity of the DREFAQ, the Modified Falls Efficacy Scale (MFES), which can evaluate the efficacy of falls and has been validated in Turkish, and the Parkinson's Disease Quality of Life (PDQOL) questionnaire, which can evaluate the quality of life and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Detailed description: The reliability and validity of the scale will begin with language equivalence and cultural adaptation. The scale will be translated from English to Turkish by two people who are fluent in Turkish and English. A single Turkish translation will be obtained from these two Turkish translations with a common opinion.

The scale, which has been translated into Turkish, will be translated into English by two other people who are fluent in Turkish and English. The scale translated into English will be compared with the original. If the developer of the scale, Frank, Anika, et al approves the translation of the scale, participants will be recruited for the study. In the pre-trial phase, a reassessment will be conducted with 15 participants to test the intelligibility of the scale. Based on the results of the pre-test phase, the final version of DREFAQ will be able to be modified. The data of DREFAQ are collecting through face-to-face when the patients came to the rehabilitation center. 50 participants will be included in the study.

In order to evaluate the validity of the DREFAQ, the Modified Falls Efficacy Scale (MFES), which can evaluate the efficacy of falls and has been validated in Turkish, and the Parkinson's Disease Quality of Life (PDQOL) questionnaire, which can evaluate the quality of life and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Eligibility criteria: Inclusion Criteria:

* Individuals with a Hoehn \& Yahr score between 1-4,
* Individuals who can ambulate with or without assistive equipment,
* Individuals with a Mini Mental State Examination score of \>24,
* Individuals with a history of falling at least once in the last year,

Exclusion Criteria:

* communication or cognitive problems,
* aphasia and speech disorders
* unstable medical conditions

Primary outcomes:
measure: Falls
timeFrame: Baseline
measure: Falls Efficacy
timeFrame: Baseline
Secondary outcomes:
measure: Quality of Life
timeFrame: Baseline
Other outcomes:
Locations:
city: İstanbul
country: Turkey
facility: İstanbul Medeniyet University
Study officials:
References: